FdaApplication
NDA 202293
Identifiers
- fda_app_no: NDA202293
Properties
| Property | Value |
|---|---|
| applicant_name | ASTRAZENECA AB |
| application_type | NDA |
| approval_date | 2014-01-08 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| FARXIGA | DAPAGLIFLOZIN | 5MG | TABLET;ORAL |
| FARXIGA | DAPAGLIFLOZIN | 10MG | TABLET;ORAL |
2 products